" class="no-js "lang="en-US"> Ali Parsa Archives - Medtech Alert
Friday, April 19, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Babylon Acquires Higi to Extend its Digital-First Healthcare Platform to Millions of People in the U.S.

Babylon today announced the closing on December 31, 2021 of its acquisition of Higi SH […]

Babylon Announces New Collaboration with Microsoft to Drive Healthcare Innovation and Improve Health Access and Affordability Around the World

Babylon, a world leading digital-first, value-based care company today announced a collaboration with Microsoft to […]

Royal Wolverhampton NHS Trust (RWT) and Babylon bring digital-first, value-based healthcare to over 55,000 people across Wolverhampton

Royal Wolverhampton NHS Trust (RWT) and Babylon today announced they have extended their partnership to bring […]

Peer-reviewed Research Finds Babylon's Digital-first Model of Primary Care is Associated With Lower Significantly NHS Hospital Care Costs

Researchers at Babylon, a leading digital-first value-based healthcare company,  have found that members of Babylon’s […]

Babylon Hires Former White House Health Official Darshak Sanghavi as New Chief Medical Officer

Babylon today announced the hiring of Darshak Sanghavi, MD as the company’s new Global Chief […]

Babylon: Meet the Largest Digital-First, Value-Based Care Provider in the United States

Babylon today announced that its recent strategic partnerships and acquisitions — combined with significant organic […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more